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Preventive Dentistry Techniques in the Treatment of 
Dental Caries and Biofilm Control: A Review 
Tyler R. Oatmen 
Abstract:  This study reviews the biological mechanisms and recent advances in preventive 
dentistry therapies that prevent the formation dental caries, covering both traditional and 
novel techniques.  The techniques covered prevent the formation of dental caries through 
two therapeutic approaches, either promoting the remineralization of the hard tooth 
surface or regulating the level and composition of the oral biofilm present in the mouth. 
Traditional therapies covered include fluoride and calcium treatments that promote the 
remineralization of the tooth surface, and antibiotic therapies that attempt to regulate oral 
biofilm levels, such as chlorhexidine, essential oils, systemic antibiotics, and salivation 
stimulating therapies.  Novel applications covered are therapies that utilize antimicrobial 
peptides, immunizations, and probiotics that may become important to dentistry in the 
near future.  Dental caries management is a complex and dynamic process, but by 
reestablishing optimal oral health through preventive techniques, dentists can preserve 
tooth structures and avoid costly and extensive restorative treatments. 
Key Words: Carious Lesions, Hydroxyapatite, Acidogenic, Phosphopeptide, Periodontitis, Xerostomia 
Background 
  Commonly referred to as cavities or tooth decay, dental caries is a disease where 
the hard tissues of the teeth have been damaged, creating cavities in the tooth.  Although 
the prevalence of dental caries has steadily declined over the last 20 years due to dental 
hygiene practices and the increased use of fluoride-containing products, health surveys still 
estimate the percentage of adults with decayed, missing, or filled tooth surfaces to be 
98.3%. (Brown)  While the disease is multifactorial in nature, the mechanism for caries 
formation is well understood.  Four main components exist in the process of caries 
formation: a tooth surface, acidogenic bacteria, fermentable carbohydrates, and time.   
Enamel and dentin are the tooth’s two outermost surfaces, and are primarily 
composed of a crystallized calcium phosphate called: hydroxyapatite.  The tooth’s 
hydroxyapatite crystal lattice exists in a constant equilibrium of demineralization and 
remineralization, which is a pH dependent process.  When the pH drops below a critical 
value (pH 5.4 to 5.5 for enamel), the acid dissolves hydroxyapatite minerals into solution. 
Demineralization of the tooth surface causes areas of tooth decay called lesions, which can 
progress into clinical dental caries.  Demineralization at the tooth surface is a reversible 
process, however, and when the pH levels recover within the mouth, the recrystallization of 
minerals upon the tooth surface occurs.  Remineralization using calcium and phosphate 
2 
 
minerals present in saliva is a slower process than the dissolution process, but promoting 
remineralization is a key action in preventing dental caries.  Fortunately, caries is not a 
disease that develops rapidly and it takes time for lesion initiation to produce a clinical 
result.  It may take up to three or four years to develop a cavitation and as a result, there 
exists ample time to interrupt the caries formation process through preventive techniques. 
(Peters)   
 Caries formation is a pH dependant process, and the fluctuation of pH within the 
oral cavity is a daily occurrence due to the presence of certain cariogenic (caries 
promoting) bacteria and fermentable carbohydrates.  The presence of microbes within the 
mouth is natural within the oral cavity, and bacteria are the most common and numerous. 
(Aas)  When bacteria such as mutans streptococci or lactobacilli colonize the oral cavity as 
a result of environmental shifts that make these bacteria more competitive, namely a 
lowered pH level, plaque formation occurs.  Oral biofilm (or plaque) is the accumulation of 
cariogenic bacteria that resides directly on the tooth surface in a diseased state.  During the 
metabolism of fermentable carbohydrates these acid producing (acidogenic) bacteria 
produce byproducts of fermentation that lower the pH of the mouth, and the dissolution of 
the tooth surface proceeds.  Both the mutans streptococci and lactobacilli families produce 
lactic acid and these two bacterial groups, either separately or together, are primary 
causative agents of dental caries.  Acidogenic bacteria promote the formation of caries, but 
the anticariogenic properties of saliva is also well established.  Saliva contains oxidative 
enzymes that function as antimicrobial agents.  Saliva also acts as a pH buffer, and contains 
calcium and phosphate ions used in the remineralization process.  Both increasing saliva 
production and mediating plaque levels in the mouth are also approaches used in 
preventive dental caries formation. 
Preventive dentistry aims to stop the progression of dental caries by promoting 
daily habits and clinical therapies that either promote the remineralization of the tooth 
surface or prevent the formation of the oral biofilm responsible for lowering the oral pH 
levels in an attempt to prevent cavity formation.  Mineral based treatments include fluoride 
or other ions that attempt to replace lost hydroxyapatite.  Methods that focus on biofilm 
control include local and systemic antibiotics or interventions that artificially increase 
saliva production.  This review will look at the mechanisms and clinical efficacy of several 
traditional preventive dentistry measures and also describe new technology that shows 
promising results in preventing dental caries.  
 
Preventing Demineralization/ Promoting Remineralization 
Fluoride Treatment 
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 The use of fluoride therapy in dentistry aims to replace lost hydroxyapatite material 
with fluoroapatite in the remineralization process by increasing the amount of available 
fluoride ions in saliva.  Fluoroapatite is the product of a reaction between fluoride and a 
calcium phosphate, producing a calcium halophosphate mineral that combines well with 
the hydroxyapatite structure of hard tooth structures.  Ten calcium ions and six phosphate 
ions form one fluoroapatite unit (Ca10(PO4)6F2).  These fluoroapatite crystals are relatively 
insoluble in comparison the hydroxyapatite crystals and as a result, repeated 
remineralization in the presence of fluoride ions results in a more caries resistant tooth 
surface.  During periods of “acid challenge” the fluoride treated tooth surface actually 
becomes more resistant to demineralization and subsequent lesion formation.  Fluoride 
has become an important tool in preventive dentistry, and fluorinated water has been 
called one of the greatest health achievements of the 20th century by the Center for Disease 
Control. 
 Topical at-home fluoride uses such as tooth pastes, mouth rinses, and gels remain a 
cost-effective way to retain a sufficient therapeutic concentration of fluoride within the 
mouth.  A recent systematic review of at-home fluoride treatments concluded that the 
benefits of daily use for preventing dental caries is firmly established.  On average, in a 
population with an average of 2 DMFS (Decayed, Missing, and Filled Surfaces) per year, 
topical fluoride agents prevented up to 0.74 DMFS per year. (Marinho)  Professionally 
applied fluoride in the form of foam, gel, and varnish has also been extensively studied, and 
the American Dental Association has recently published guidelines for the clinical use of 
fluoride treatments.  The report concluded that children and adults with any risk factors or 
existing cavitations should receive clinical fluoride application at a minimum of six month 
intervals. (JADA)  The ADA cautions against the overuse and unnecessary application in 
children to prevent fluorosis, but concludes that fluoride application is beneficial in both 
the treatment and prevention of dental caries. 
  An alternate method of delivering fluoride concentrations to the tooth-biofilm 
interface at a consistent concentration over time are slow-release systems.  The slow-
release systems utilize a dental device that is placed upon a molar tooth surface that 
provides a controlled sustained release of fluoride ions.  Historically slow-release systems 
have either been a copolymer design or a glass device.  Copolymer devices consist of 
sodium fluoride ions surrounded by a HEMA/MMA copolymer membrane that provides a 
controlled rate of fluoride release as the materials become hydrated and granulated NaF 
are released. (Pessan)  Glass devices, which were innovated initially from animal 
husbandry devices that delivered trace elements to animals with deficiencies, utilize a 
dome or disk shaped glass material containing fluoride ions.  Attachment via a plastic 
mounting bracket allows the glass device to dissolve fluoride ions into solution when 
moistened.  Slow-release systems are typically applied to only high risk patients that 
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experience problems with compliance to an at-home fluoride routine.  Each individual 
slow-release system is typically rated based on fluoride retention rates intraorally, as a 
fluoride level of 0.1 ppm in saliva have been identified as an optimal therapeutic level. 
(Featherstone)  Both copolymer and glass devices are effectively able to achieve this level, 
with some studies concluding that benefical levels of up to 0.69 ppm are achieved. 
Calcium Phosphate Treatments 
 Fluoride alone cannot achieve remineralization, the presence of calcium and 
phosphate ions are also required.  Increasing concentrations of calcium and phosphate ions 
in saliva while effective fluoride levels are present has become a clinical strategy for non-
invasive remineralization of the tooth surface.  The calcium and phosphate ions can 
become the limiting factor for remineralization, especially in cases of xerostomia (dry 
mouth) where low saliva levels exist.  Past systems that have attempted to deliver calcium 
and phosphate ions have experienced troubles with the solubility of these ions at neutral 
pH ranges.  A number of commercialized systems have claimed to increase the intraoral 
calcium and phosphate ion concentrations, and a recent report has examined the 
anticariogenic efficacy of these systems. (Reynolds)   
One commercialized system that has displayed superior efficacy is the casein 
phosphopeptide stabilized system.  This technology utilizes phosphopeptides from the 
casein family of proteins to stabilize a large amount of calcium phosphate at the tooth 
surface by binding the phosphopeptide to the plaque-enamel interface.  The casein 
phosphopeptide contains the cluster sequence –Ser-Ser-Ser-Glu-Glu-,  which stabilizes the 
amorphous calcium phosphate into nanoclusters that do not perform nucleation or 
crystallization, thus keeping the calcium phosphate soluble in the delivery solution. (Cross)  
When delivered, the casein phosphopeptide amorphous calcium phosphate complex (CPP-
ACP complex) attaches to the tooth surface, and the amorphous calcium phosphate is free 
to participate in the remineralization process.  The anticariogenic properties of this system 
have been confirmed in a recent clinical trial. (Morgan)  The CPP-ACP complex is typically 
incorporated into a commercial product such as chewing gum, milk, mouthrinse, or a paste 
for at home use.  Other systems are being developed and have shown efficacy within animal 
models or in vitro trials, but have yet to achieve clinical trial results. 
Controlling Biofilm/ Plaque Levels  
 In addition to focusing on the remineralization of the tooth surface as a way to 
combat dental caries, preventive dentistry also seeks to control the bacteria that make 
demineralization possible.  Current treatments within preventive dentistry most often seek 
to kill the microbes within the mouth with antibacterial agents delivered locally, through 
the use of systemic antibiotics, or through the stimulation of saliva production.  Typically 
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antimicrobial agents target both supra-gingival plaque, and more importantly sub-gingival 
plaque buildup.  Sub-gingival plaque is difficult to remove with regular dental hygiene 
habits, and the ability to control the levels and growth of bacteria at the sub-gingival level 
is an important part in controlling root caries formation.  It is important to note however 
that the simple elimination of microbes within the mouth may not produce the best 
outcome for the dental patient.  The mouth is a rich mixture of microorganisms that, when 
present at the right composition within the mouth, provide benefits to their human hosts.  
Therefore, preventive dentistry methods should try to control the levels of bacteria within 
the mouth to achieve a level of plaque that is consistent with optimal oral health.  Clinical 
decisions to deliver antimicrobial agents exist in a balance between delivering relevant and 
clinically measurable amounts, but at the same time not disrupting the natural ecology of 
the mouth which provides protection from opportunistic pathogens and the overgrowth of 
exogenous microbes.  A closer look into the mechanism of action, delivery methods, and 
retention in the mouth of these antimicrobial agents is essential in making preventive 
dentistry treatment decisions.   
Topical/Local Methods for Biofilm Control 
 Chlorhexidine:  Currently mouthrinses that contain 0.12% chlorhexidine are 
marketed within the United States.  Chlorhexidine is a broad spectrum antibiotic that kills 
Gram-positive and Gram-negative bacteria as well as yeasts at high concentrations.  At 
lethal concentrations chlorhexidine causes irreparable damage to the cell membrane of 
target microbes, and at sub-lethal concentrations chlorhexidine can interfere with the 
sugar transport and acid production of the cariogenic streptococci strains, providing a 
bacteriostatic effect.  Chlorhexidine is typically utilized because of its great retention within 
the plaque coated enamel surface, and studies report that 30% of the delivered 
chlorhexidine is retained in the mouth after use. (Marsh)  The efficacy of the chemical has 
come under scrutiny as some clinical trials have failed to produce significant level of caries 
reduction, and side effects such as staining and an altered taste sensation have been 
reported. (Autio-Gold)  Chlorhexidine’s retention rate and broad spectrum antibacterial 
action make it a great candidate for the control of plaque, but the recent questionable 
nature of the long-term clinical evidence for caries prevention and possible undesirable 
side effects should be considered before clinical recommendation. 
 Essential Oils:  Essential oils are by definition hydrophobic liquids that are extracted 
from plants, typically bearing some distinctive scent or ‘essence’.  The two oils typically 
used in mouthrinses are thymol and eucalyptol.  Mouthrinses containing both 
chlorhexidine and essential oils are approved through the American Dental Association, 
and essential oil therapy does not exhibit the unwanted side effects of chlorhexidine use, 
potentially increasing patient compliance with the treatment.  Additionally, essential oils 
have not shown any production of antimicrobial resistance over long term use, which 
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makes a prolonged treatment period possible.  The mechanisms of action against bacteria 
are complex.  At high concentrations the oils are lethal, disrupting the cell wall and causing 
precipitation of cell proteins, and at low concentrations the oils inactivate essential 
bacterial enzymes.  The oils have been shown to penetrate the plaque biofilm and exert a 
bactericidal activity in embedded bacteria, effectively reducing the bacterial load and 
slowing plaque mass and pathogenicity. (Stoeken)  The plaque reducing properties of both 
essential oils and chlorhexidine therapies is proven, but these therapies should never be 
used exclusively to prevent caries.  Plaque buildup is only one portion of the etiology for 
dental caries, and prevention techniques should be used in concert to ensure the best 
patient outcome.   
Systemic Antibiotics 
 Systemic antibiotics are antibiotic drugs delivered orally that affect the mouth as 
well as the whole body.  The most common forms of antibiotics used are tetracyclines, 
penicillins, metronidazole, macrolides, clinamycin, and ciprofloxacin.  The literature does 
not provide a clear indication of the superiority of one antibiotic regimen over the other, 
and because various antibiotics target various species of microbes, the treatment decision 
should made be on an individual basis.  Systemic antibiotics have been advocated in the 
control of subgingival plaque levels only in accompaniment with non-surgical debridement 
and regular periodontal maintenance.  Typically patients with some level of periodontal 
disease, the disease that affects the supporting tissues of the mouth, are clinically 
considered for systemic antibiotic therapy.  Systemic antibiotics have severe limitations in 
that long term use or overuse of antibiotics can lead to bacterial resistance and that the 
affected areas of the body cannot be limited to just the mouth.  Therefore the use of 
systemic antibiotics has been confined to patients with existing levels of plaque that are 
causing some form of periodontitis.  A recent study confirms the effectiveness of systemic 
antibiotics when used in conjunction with mechanical debridement of plaque. (Heitz-
Mayfield)  While systemic antibiotics are used in concert with other methods on a short 
term basis to achieve a level of plaque that is consistent with optimal oral health, the 
method should be utilized with care as to not produce bacteria that are antimicrobial 
resistant. 
Altering Saliva Production 
 Saliva is a major protective factor in the oral cavity, and a reduction in saliva output 
can occur from numerous systemic diseases and pharmaceutical interventions.  The 
importance of saliva output in caries prevention is a relatively new topic in preventive 
dentistry, but pharmaceutical interventions have commonly treated the xerostomia that 
accompanies many drug therapies (eg. chemotherapy).  Loss of antimicrobial capacity, pH 
buffering, and remineralization properties of saliva may lead to rapid and severe caries 
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formation, and may also leave the mouth susceptible to infections, mucosal pain, and 
difficulties chewing and swallowing.  By increasing salivary function and its natural 
protective factors, these oral complications can be avoided and, when combined with other 
caries prevention techniques, can provide a synergistic approach in prevention of caries 
formation. 
 Clinical attempts at increasing secretory output first start at a local level within the 
mouth, and typically begin by increasing oral activity.  Salivation physiologically increases 
in response to chewing or taste, particularly sour and bitter tastes.  The use of sugar-free 
gums and lozenges will increase salivary output for a patient, and still remains the 
mainstay therapy for patients suffering from xerostomia (dry mouth).  The use of sugar-
free methods of increasing oral activity must be stressed, as the additional sugar ‘coating’ 
would only increase dental caries risk, negating the potential benefits of increased saliva 
production.  Other topical therapies include artificial salivas that attempt to mimic the 
composition and abilities of natural saliva in the forms of oral rinses, gels, and flavored 
mouthwashes.  These topical treatments are limited however by their transient nature, and 
stimulating saliva output over a prolonged period of time would be more desirable. 
 Several systemic agents that can stimulate saliva production can have a more 
profound and consistent effect.  Pilocarpine is the drug with the most extensive background 
of clinical evidence, as it has been a treatment for dry mouth for over 100 years.  
Pilocarpine was initially utilized in Sjogren’s syndrome and postradiation therapy to 
stimulate salivary gland production.  Pilocarpine is a parasympathomimetic agent with a 
mild β-adrenergic stimulating property that can be utilized without serious adverse side 
effects, although treatment for patients with cardiovascular disease is not advised.  The 
majority of the studies have used dry mouth symptoms as primary outcome variables, but 
recently oral dryness and salivary secretion has been measured in clinical trials.  Studies 
find that pilocarpine maximally stimulates salivary secretion approximately 1 hour after a 
dose and increases in baseline output are found for 3-4 hours afterwards. (Wiseman)  
Although pilocarpine has not been shown to increase baseline salivary secretion, the 
increased salivary output is dose-related and consistent.  Typically an orally ingested form 
of pilocarpine HCL is delivered 3 times a day, and common side effects include excess 
sweating and urination.  Cevimeline is a drug that has recently gained clinical backing in 
increasing salivary output. (Petrone)  The pharmacological profile is very similar to 
Pilocarpine, and the important properties of the drug are the later onset time and longer 
duration of the action.  A therapy using a combination of both Pilocarpine and Cevimeline is 
under review, that could potentially deliver a longer lasting, consistent increase in saliva 
production. 
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Novel Technology 
 The aforementioned therapies have all been identified as useful for preventive 
dentistry and are at various stages of clinical trials.  To look into the future of preventive 
dentistry measures, the literature concerning promising advances in potentially useful 
technologies for the prevention of dental caries and the control of biofilm was reviewed.  
The following is a description of potential technologies that may become important in the 
advancement of preventive therapies, including antimicrobial peptides, immunizations, 
and probiotics. 
Antimicrobial Peptides 
 An important issue with chemotherapies and antimicrobial therapies today is the 
proliferation of antibiotic-resistant organisms that lessen the efficacy of conventionally 
utilized antibiotics.  Just recently antimicrobial peptides (AMPs) have come forward as 
agents that exhibit a wide spectrum antimicrobial activity against bacteria, including drug-
resistant strains.  Antimicrobial peptides vary in their peptide sequence and 
posttranslational modifications, but the majority of AMPs are amphipathic mixtures of α–
helical and β–sheet structures with a cationic charge. (Pazgier)  The action of AMPs 
typically involves binding to the negatively charged functional groups of microbial 
membranes (eg. lipopolysaccharides) and creating a disruption by insertion into the 
membranes, although it has been suggested that a number of AMPs translocate 
intracellularly and are lethal via a different mechanism. (Zasloff)   
 Commercial applications of AMPs have stalled due to the difficulty and expense of 
their manufacture, and their relatively short half-lifes due to enzyme degradation. (Marr)  
Several solutions have recently been proposed to make AMP therapies less expensive, one 
being the use of exogenous modifiers to increase AMP transcription levels rather than 
directly using the peptide. The 25-dihydroxyvitamin D3 vitamin is a biologically active 
form of vitamin D that has recently been discovered to induce the expression of the 
Cathelicidin antimicrobial peptide family in the human genome without a large amount of 
host immune response. (Wang)  Another solution that may become useful are non-peptidic 
polymers that resemble natural AMP compounds, adopting the amphiphilic structure 
similar to AMPs and exhibiting the same antimicrobial activity.  These compounds are 
much cheaper to manufacture, and a recent study showcased the ability to act specifically 
against bacterial families.  A pheromone produced by S. Mutans, a cariogenic bacteria, was 
used to deliver lethal nanomolar concentrations of synthetic AMP directly to the S. Mutans 
bacteria and did not affect other streptococci that were present. (Eckert)  Researchers 
linked an AMP peptide sequence to the S. Mutans pheromone peptide sequence using a 
chain of amino acids, termed the linker region.  The functionality of both the pheromone 
and the AMP remained consistent, and the resulting peptide showed specific lethality to the 
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S. Mutans bacteria.  This pheromone-guided ‘smart’ antimicrobial peptide potentially 
achieves a level of clinical specificity that avoids the clearance of all bacteria within the 
domain, protecting the host from opportunistic pathogens.  Specifically targeted 
antimicrobial peptides (STAMP’s) could be delivered in current oral care products such as 
mouthwash, toothpaste, or dental floss and could help with the suppression of cariogenic 
bacteria.  Recently, reports of AMPs that are down to simply 10 peptides long have been 
published, and in consideration of the relative stability and cost to produce peptides 
commercially, smaller peptides do hold promise.  Researcher’s knowledge of antimicrobial 
peptides is a rapidly advancing, and AMPs certainly have the potential to become ideal 
antimicrobial agents in the future of dentistry. 
Immunizations 
 The body’s natural lines of defense can also be utilized in the fight against cariogenic 
bacteria of the mouth.  Recent work has focused on using S. mutans antigens to initiate an 
antibody secretion, and subsequently eliminate S. mutans colonization in the body.  
Immune defense from dental caries is mediated mainly by secretory IgA (sIgA) antibodies 
produced in the oral mucosa.  Mucosal immunization with antigens at the local lymphoid 
tissues, including the gut-associated and nasopharynx-associated lymphoid tissue, results 
in the migration of IgA-producing B cells to the salivary glands.   
 The main type of S. mutans antigen involved for which specific sIgAs have been 
found is Antigen I/II.  Antigen I/II is the surface adhesion protein of the bacteria and 
contains an alanine-rich tandem-repeating region, and a proline rich repeat region 
associated with adhesion activity. (Shivakumar)  The antigen I/II specific sIgA is able to 
inhibit the adhesion of S. mutans to hydroxyapatite and their subsequent colonization on 
the tooth surface. (Hajishengallis)  Animal models of antigen I/II’s effect upon caries 
formation are promising, but more clinical trials are required before the effect can be 
translated to human populations.  Other studies have focused on the binding of S. mutans to 
sugars within the oral biofilm.  Vaccines focused on the glucosyltransferase enzymes and 
glucan-binding proteins of the bacteria have also been tested.  Both of these methods have 
been shown to mediate an exaggerated immune response, inhibiting the aggregation of S. 
mutans in animal models to some degree. (Taubman) (Smith)  
Probiotics 
 As mentioned before, treatment intending to wipe out the entire oral flora may have 
undesired consequences in the form of secondary infections.  Today’s efforts in caries 
research have begun to focus on strategies to selectively inhibit oral pathogens by 
outcompeting or killing the bacteria with additional bacteria.  Stemming from the success 
that the probiotics field have seen in gastrointestinal diseases, probiotics are now being 
developed that disrupt the attachment of cariogenic bacteria via competition for binding 
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sites at the biofilm, and competition for nutrients within the biofilm.  Probiotic strains are 
also being produced that can secrete antimicrobial compounds, potentially inhibiting 
pathogenic oral bacterium.   
 Some gastrointestinal strains of bacteria have been tested in clinical trials to control 
the growth of cariogenic bacteria.  Recently a study concluded that long term consumption 
of milk containing a L. rhamuosus strain reduced the incidence of caries in kindergarten 
children.(Nase)  Ingestion of other bacteria, namely strains of lactobacillis, have shown 
antibacterial activity against S. mutans as well as good oral mucus binding characteristics 
that successfully mediates levels of pathogenic bacteria via direct competition. (Nase)  One 
of the most interesting avenues of probiotics comes in the form of DNA recombination 
therapy.  Termed DNA replacement therapy, the technology has allowed researchers to 
mutate S. mutans into bacteria that lack enzymes to metabolize fermentable carbohydrates 
into organic acids.  This significantly less cariogenic strain is genetically stable, never 
reverting back to acid producing bacteria in both in vivo and in vitro tests, and is currently 
undergoing human efficacy trials. (Hillman)  DNA therapy that aims to replace cariogenic 
bacteria with less pathogenic clones of themselves could someday become a key tool in 
preventing caries formation. 
Conclusion 
 The field of preventive dentistry will certainly benefit from new technology in the 
future as well as the ongoing research into optimizing traditional approaches.  Determining 
the correct treatment plan should always be made on an individual basis, taking into 
account existing dental carious lesions and future caries risk of the patient.  Preventive 
techniques are most often dependent upon the patient’s compliance to the prescribed 
therapy, and motivating the patient to follow the treatment plan plays a key role in a 
successful outcome.  An increased amount of technologies are aimed at promoting tooth 
remineralization, but fluoride remains the most widely agent in managing the formation of 
caries due to its strong levels of clinical evidence.  When fluoride therapy is not enough to 
overcome the formation process, dentists should consider a synergistic approach at 
preventing caries.  Combining therapies that promote saliva production, increase the 
intraoral calcium and phosphate ion concentrations, and provide antimicrobial therapy can 
lead to more pronounced results.  Novel technologies should only be considered adjuncts 
to treatments when their caries-preventing properties can be demonstrated in randomized 
controlled clinical trials. 
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